205 related articles for article (PubMed ID: 3015772)
1. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS.
Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR
Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772
[TBL] [Abstract][Full Text] [Related]
2. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
[TBL] [Abstract][Full Text] [Related]
3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
[TBL] [Abstract][Full Text] [Related]
4. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.
Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH
Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805
[TBL] [Abstract][Full Text] [Related]
5. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
[TBL] [Abstract][Full Text] [Related]
6. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
[TBL] [Abstract][Full Text] [Related]
7. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
[TBL] [Abstract][Full Text] [Related]
8. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
[TBL] [Abstract][Full Text] [Related]
10. Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men.
Evans BA; Dawson SG; McLean KA; Teece SA; Key PR; Bond RA; Macrae KD; Jesson WJ; Mortimer PP
Genitourin Med; 1986 Dec; 62(6):384-9. PubMed ID: 3469139
[TBL] [Abstract][Full Text] [Related]
11. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.
Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC
Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878
[TBL] [Abstract][Full Text] [Related]
12. Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy.
Mayer KH; Ayotte D; Groopman JE; Stoddard AM; Sarngadharan M; Gallo R
Am J Med; 1986 Mar; 80(3):357-63. PubMed ID: 3006486
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
[TBL] [Abstract][Full Text] [Related]
14. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.
Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M
Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle.
Collier AC; Barnes RC; Handsfield HH
Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580
[TBL] [Abstract][Full Text] [Related]
16. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
[TBL] [Abstract][Full Text] [Related]
17. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London.
Gazzard BG; Shanson DC; Farthing C; Lawrence AG; Tedder RS; Cheingsong-Popov R; Dalgleish A; Weiss RA
Lancet; 1984 Sep; 2(8401):480-3. PubMed ID: 6147547
[TBL] [Abstract][Full Text] [Related]
18. Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
Kaplan JE; Oleske JM; Getchell JP; Kalyanaraman VS; Minnefor AB; Zabala-Ablan M; Joshi V; Denny T; Cabradilla CD; Rogers MF
Pediatr Infect Dis; 1985; 4(5):468-71. PubMed ID: 2995933
[TBL] [Abstract][Full Text] [Related]
19. Three-year prospective study of HTLV-III/LAV infection in homosexual men.
Weber JN; Wadsworth J; Rogers LA; Moshtael O; Scott K; McManus T; Berrie E; Jeffries DJ; Harris JR; Pinching AJ
Lancet; 1986 May; 1(8491):1179-82. PubMed ID: 2871421
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
